Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 7
1950 7
1951 5
1954 2
1955 1
1956 1
1957 1
1958 1
1960 2
1961 1
1962 2
1964 3
1965 1
1966 1
1967 4
1968 2
1969 2
1970 5
1971 7
1972 2
1973 2
1974 3
1975 3
1976 1
1977 3
1978 2
1979 3
1980 1
1981 3
1982 4
1983 3
1984 3
1986 4
1987 4
1988 1
1989 1
1991 1
1993 5
1994 1
1995 2
1996 5
1997 2
2001 3
2002 6
2003 7
2004 5
2005 4
2006 4
2007 2
2008 3
2009 5
2010 5
2011 10
2012 7
2013 13
2014 7
2015 7
2016 6
2017 3
2018 7
2019 6
2020 6
2021 14
2022 13
2023 17
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Results by year

Filters applied: . Clear all
Page 1
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N, Natarajan K, Rundback J, Sadiq IR, Liu SK, Bhalla N, Raja ML, Weinstock BS, Cynamon J, Elmasri FF, Garcia MJ, Kumar M, Ayerdi J, Soukas P, Kuo W, Liu PY, Goldhaber SZ; SEATTLE II Investigators. Piazza G, et al. Among authors: sterling km. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1382-1392. doi: 10.1016/j.jcin.2015.04.020. JACC Cardiovasc Interv. 2015. PMID: 26315743 Free article. Clinical Trial.
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study.
Klok FA, Piazza G, Sharp ASP, Ní Ainle F, Jaff MR, Chauhan N, Patel B, Barco S, Goldhaber SZ, Kucher N, Lang IM, Schmidtmann I, Sterling KM, Becker D, Martin N, Rosenfield K, Konstantinides SV. Klok FA, et al. Among authors: sterling km. Am Heart J. 2022 Sep;251:43-53. doi: 10.1016/j.ahj.2022.05.011. Epub 2022 May 16. Am Heart J. 2022. PMID: 35588898 Free article. Clinical Trial.
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.
Tapson VF, Sterling K, Jones N, Elder M, Tripathy U, Brower J, Maholic RL, Ross CB, Natarajan K, Fong P, Greenspon L, Tamaddon H, Piracha AR, Engelhardt T, Katopodis J, Marques V, Sharp ASP, Piazza G, Goldhaber SZ. Tapson VF, et al. Among authors: sterling k. JACC Cardiovasc Interv. 2018 Jul 23;11(14):1401-1410. doi: 10.1016/j.jcin.2018.04.008. JACC Cardiovasc Interv. 2018. PMID: 30025734 Free article. Clinical Trial.
Reply to Khoury and Hakim.
Sterling KL, Wedzicha JA, Malhotra A. Sterling KL, et al. Am J Respir Crit Care Med. 2023 Jan 15;207(2):222-223. doi: 10.1164/rccm.202208-1598LE. Am J Respir Crit Care Med. 2023. PMID: 36049220 Free PMC article. No abstract available.
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis.
Trauner M, Chung C, Sterling K, Liu X, Lu X, Xu J, Tempany-Afdhal C, Goodman ZD, Färkkilä M, Tanaka A, Trivedi P, Kowdley KV, Bowlus CL, Levy C, Myers RP. Trauner M, et al. Among authors: sterling k. BMC Gastroenterol. 2023 Mar 15;23(1):75. doi: 10.1186/s12876-023-02653-2. BMC Gastroenterol. 2023. PMID: 36922785 Free PMC article. Clinical Trial.
264 results